Teva Pharmaceutical Industries will collaborate with French drugmaker Sanofi to develop a treatment for inflammatory bowel disease it hopes will become a blockbuster drug.
https://www.pharmalive.com/wp-content/uploads/2021/06/New-York-takes-Teva-McKesson-others-to-trial-over-opioids-Reuters-6-29-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-10-04 09:53:202023-10-04 10:53:15Teva hopes Sanofi collaboration will lead to blockbuster IBD drug
